[
  {
    "ts": "2025-12-24T03:10:15+00:00",
    "headline": "FDA Infant Formula Warning Could Be A Game Changer For Walmart’s (WMT) Tech-Driven Retail Strategy",
    "summary": "In recent weeks, Walmart has faced an FDA warning letter over recalled ByHeart infant formula remaining on sale in dozens of its stores, even as it expands branded offerings like Dove x Crumbl self-care products and signs new retail agreements with No Cap! Soda Pop and AXIL hearing protection. At the same time, Walmart filed a new US$16.53 billions ESOP-related shelf registration, closed two prior ESOP shelves, and continued to attract attention for insider share sales and its transition to...",
    "url": "https://finance.yahoo.com/news/fda-infant-formula-warning-could-031015530.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "9dc5237c-7351-34ef-b8a1-3eedc99cedfb",
      "content": {
        "id": "9dc5237c-7351-34ef-b8a1-3eedc99cedfb",
        "contentType": "STORY",
        "title": "FDA Infant Formula Warning Could Be A Game Changer For Walmart’s (WMT) Tech-Driven Retail Strategy",
        "description": "",
        "summary": "In recent weeks, Walmart has faced an FDA warning letter over recalled ByHeart infant formula remaining on sale in dozens of its stores, even as it expands branded offerings like Dove x Crumbl self-care products and signs new retail agreements with No Cap! Soda Pop and AXIL hearing protection. At the same time, Walmart filed a new US$16.53 billions ESOP-related shelf registration, closed two prior ESOP shelves, and continued to attract attention for insider share sales and its transition to...",
        "pubDate": "2025-12-24T03:10:15Z",
        "displayTime": "2025-12-24T03:10:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4559202443400de02cb22c3c39f33e03",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r4r1G1eFsl6QfUy6gLgJHg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4559202443400de02cb22c3c39f33e03.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nUAELTZkZtSvOC2PvSjdBQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4559202443400de02cb22c3c39f33e03.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fda-infant-formula-warning-could-031015530.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-infant-formula-warning-could-031015530.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WMT"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]